Sequent Scientific Limited
Sequent Scientific is India's leading animal health company, with presence in 5+ continents across 100 countries. Sequent Scientific Limited provides a wide-ranging portfolio of animal health products, including Finished Dose Formulations, APIs, as well as analytical services to the pharmaceutical and life sciences industries.
What Sequent files
- Others49
- Important25
- Updates19
- Investor Meet18
- Board Meeting9
- PPTs5
Viyash Scientific's subsidiary, Alivira Animal Health, partnered with Boehringer Ingelheim for companion animal product distribution in India. This strategic move aims to capture India's growing pet healthcare market and enhance market reach.
Viyash Scientific Limited has scheduled a conference call with analysts and investors on February 06, 2026, at 9:00 a.m. (IST). The call is planned to discuss the company's Q3FY26 financial results.
Sequent Scientific Limited will soon be known as Viyash Scientific Limited, with its trading symbol changing to VIYASH. This significant operational update reflects a business development for the company.
Crisil has withdrawn ratings for Symed Labs Limited's bank facilities. This follows Symed's amalgamation with Viyash Lifesciences, which subsequently merged into Viyash Scientific Limited. Symed Labs ceased to exist as a separate entity, leading to the rating withdrawal as per Crisil's policy.
Sequent Scientific Limited has officially changed its name to Viyash Scientific Limited after receiving all necessary approvals. This business development is now complete, with filings underway at stock exchanges. Investors note the new identity.